The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Viventures, Ping An Ventures, Hermed Capital.
Among the most popular portfolio startups of the fund, we may highlight Applied StemCell. Among the most popular fund investment industries, there are Biotechnology, Genetics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2016.
| Fund Name | Location |
| Ange Basile | - |
| Arab Bank (Switzerland) | Geneva, Geneve, Switzerland |
| Asas Capital | Dubai, United Arab Emirates |
| Bouygues Immobilier | Casablanca, Grand Casablanca, Morocco |
| Coghill Capital Management | Chicago, Illinois, United States |
| Coris Bank International | Burkina Faso, Kadiogo, Ouagadougou |
| DPE Deutsche Private Equity | Bayern, Germany, Munich |
| Elevance Renewable Sciences | Illinois, United States, Woodridge |
| Great American Insurance Group | Cincinnati, Ohio, United States |
| Kawasaki Heavy Industries | Japan, Kyotango, Kyoto Prefecture |
| Lauxera Capital Partners | France, Ile-de-France, Paris |
| Martinson Ventures | - |
| Meridian Growth Capital | England, Southampton, United Kingdom |
| Monex Precious Metals | California, Newport Beach, United States |
| Pacific Structures | California, San Francisco, United States |
| Reliance Retail | India, Maharashtra, Mumbai |
| Shengtai Xinli | Beijing, Beijing, China |
| Talkot Capital | California, Sausalito, United States |
| Tectonic Ventures | Cambridge, Massachusetts, United States |
| Trend Investment Group | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BCY Pharm Co., Ltd | $1M | 14 Aug 2015 | Gusu District, Jiangsu, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BCY Pharm Co., Ltd | $1M | 14 Aug 2015 | Gusu District, Jiangsu, China |
